Sherman Michael A.
SEC-identified person · CIK 1509463 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aktis Oncology, Inc. AKTS | Director | filed 2026–2026 |
| Werewolf Therapeutics, Inc. HOWL | Director | filed 2021–2025 |
| Chimerix INC CRMX | Director · Chief Executive Officer | filed 2019–2025 |
| Biospecifics Technologies Corp [BSTC.NGM] | Director | filed 2020–2020 |
| Endocyte INC ECYT | Director · President, CEO and CFO | filed 2011–2018 |
| Mead Johnson Nutrition Co MJN | Director | filed 2015–2017 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.